 |
|
|
|
|
|
National Disease Research Interchange (NDRI)
8 Penn Center
1628 JF Kennedy Boulevard, 8th Floor
Philadelphia, PA 19103
URL: www.ndriresource.org
Grant No. U42 RR06042 |
For information about this
service and how to access its resources, please contact:
Principal Investigator/Research Director
John T. Lonsdale, Ph.D.
800-222-6374 x 271 or 215-557-7361 x 228; Fax: 215-557-7154
E-mail:
jlonsdale@ndriresource.org
|
|
NDRI is a nonprofit organization that procures and distributes
normal and diseased human tissues for laboratory research studies
to investigators in academia, government, and industry.
Tissue donation provides an opportunity for people who wish to
become organ donors, but whose tissues cannot qualify for
transplantation and might otherwise be discarded. Studies with
human tissue also serve as alternatives to the use of live
animals in research.
NDRI tissue sources include hospitals, eye and tissue banks,
and organ procurement organizations. Services are customized
to the needs of each individual research program.
Researchers who wish to receive tissue must complete an
application form. Requested tissue specifications may
include age, sex, race, aspects of medical history, sample
size, post mortem or shipment time constraints, and other
handling and processing parameters. Recipients of tissue
are required to acknowledge NDRI as the tissue source in
resultant publications. The NDRI bibliography of such
publications is available upon request.
Applications are reviewed for feasibility by a
scientific Feasibility Review Committee and NDRI staff.
All approved researchers agree to use tissue obtained
through NDRI for laboratory research purposes only and
not to resell or redistribute tissue. Approved researchers
are entered into a queue for the appropriate tissue.
Each researcher is served in turn when his/her requested
tissue becomes available. Investigators stipulate the
frequency and quantity of tissue they wish to receive,
but may ask NDRI to interrupt shipments temporarily.
NDRI makes every effort to retrieve, process, and deliver
biomaterials as requested by investigators and consistent
with their intended use. The quality of samples is closely
monitored from the time of procurement from the tissue
source through packing, shipment, and delivery. Each shipment
is accompanied by a request for information about shipment
quality. This information is tracked to maintain quality
service and investigator satisfaction.
|
 |
|
